MetLife, Inc.
MET
75.94
USD+0.75
(+1.00%)Day's range
75.5
76.75
52 wk Range
65.21
89.05
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 67,842,000,000 | 63,653,000,000 | 67,822,000,000 | 66,407,000,000 | 69,897,000,000 | |
| Gross Profit | 67,842,000,000 | 63,653,000,000 | 67,822,000,000 | 65,913,000,000 | 70,986,000,000 | |
| Operating Income | 6,927,000,000 | 8,518,000,000 | 6,364,000,000 | 2,162,000,000 | 5,622,000,000 | |
| Net Income | 5,407,000,000 | 6,855,000,000 | 5,284,000,000 | 1,578,000,000 | 4,426,000,000 | |
| Total Assets | 795,146,000,000 | 759,708,000,000 | 663,072,000,000 | 687,584,000,000 | 677,457,000,000 | |
| Total Current Liabilities | 393,000,000 | 341,000,000 | 0 | 505,000,000 | 1,552,000,000 | |
| Total Equity | 74,817,000,000 | 67,749,000,000 | 30,125,000,000 | 30,253,000,000 | 27,703,000,000 | |
| Free Cash Flow | 11,639,000,000 | 12,347,000,000 | 13,044,000,000 | 13,721,000,000 | 14,598,000,000 | |
| Cash from Operations | 11,639,000,000 | 12,347,000,000 | 13,044,000,000 | 13,721,000,000 | 14,598,000,000 | |
| Cash from Investing | -18,569,000,000 | -11,187,000,000 | -2,620,000,000 | -10,246,000,000 | -11,493,000,000 | |
| Cash from Financing | 10,729,000,000 | -1,375,000,000 | -9,948,000,000 | -2,940,000,000 | -3,131,000,000 | |
| Net Change in Cash | 3,197,000,000 | -444,000,000 | 79,000,000 | 444,000,000 | -571,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy